Nanotess
1 known investors
NanoTess develops NanoSALV Catalytic, a Health Canada authorized medical device that uses catalytic technology to optimize skin and wound healing, reduce inflammation, and provide a broad-spectrum antimicrobial effect for injured, inflamed, or infected skin. Used by physicians and surgeons across Canada, it is distributed through hospitals, healthcare facilities, and pharmacies nationwide.
Investors · 1
Frequently asked questions
- What does Nanotess do?
- NanoTess develops NanoSALV Catalytic, a Health Canada authorized medical device that uses catalytic technology to optimize skin and wound healing, reduce inflammation, and provide a broad-spectrum antimicrobial effect for injured, inflamed, or infected skin. Used by physicians and surgeons across Canada, it is distributed through hospitals, healthcare facilities, and pharmacies nationwide.
- Who are Nanotess's investors?
- Nanotess's investors include Thin Air Labs.